Evaxion Biotech A/S (EVAX)
NASDAQ·Healthcare·Biotechnology
$4.34
+3.83%
Mkt Cap $19.45M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $7.50M | $22.04K | -99.71% | -$0.24 | -$1.00 | -308.16% | — | — |
| Q4 2025 Nov 6, 2025 | — | $7.49M | — | — | $0.73 | — | — | — |
| Q3 2025 Aug 14, 2025 | $8.00M | $37.00K | -99.54% | -$0.50 | -$0.76 | -52.00% | — | — |
| Q2 2025 May 27, 2025 | $60.00K | — | — | -$0.65 | -$0.29 | +55.38% | — | — |
| Q1 2025 Mar 26, 2025 | $1.66M | $122.00K | -92.65% | -$0.26 | -$0.80 | -207.69% | — | — |
| Q4 2024 Oct 31, 2024 | $1.66M | $3.02M | +81.80% | -$0.60 | -$0.20 | +66.67% | — | — |
| Q3 2024 Aug 14, 2024 | $120.00K | $154.00K | +28.33% | $0.10 | -$0.60 | -700.00% | — | — |
| Q2 2024 May 28, 2024 | $40.00K | $51.00K | +27.50% | -$0.56 | $0.15 | +126.79% | — | — |
| Q1 2024 Mar 27, 2024 | — | $73.00K | — | -$1.60 | -$0.80 | +50.00% | — | — |
| Q4 2023 Dec 19, 2023 | — | — | — | -$0.19 | -$10.50 | -5426.32% | — | — |
| Q3 2023 Aug 18, 2023 | — | — | — | -$0.21 | -$10.50 | -4900.00% | — | — |
| Q2 2023 May 31, 2023 | — | — | — | -$0.24 | -$12.00 | -4900.00% | — | — |
| Q1 2023 Mar 28, 2023 | — | — | — | -$0.28 | -$0.39 | -39.29% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$17.00 | -$12.00 | +29.41% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$16.50 | -$10.00 | +39.39% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$17.50 | -$12.50 | +28.57% | — | — |
| Q1 2022 Mar 22, 2022 | — | — | — | -$15.00 | -$19.50 | -30.00% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$0.34 | -$0.27 | +20.59% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.29 | -$0.36 | -24.14% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$16.50 | -$11.50 | +30.30% | — | — |